Ascent Pharmaceuticals recalls
Ascent Pharmaceuticals appears in 3 official U.S. recall notices indexed by RecallRadar, most recently on 2021-12-15.
Company names are normalized from agency data (legal suffixes removed), so related firms may appear under separate pages.
Recall summary
| Recall notices | 3 |
|---|---|
| Published | 2018-02-07 to 2021-12-15 |
| By agency | FDA Drug (3) |
| By classification | Class II (2), Class III (1) |
| By status | terminated (3) |
| Distribution named in notices | US |
Recalls
- Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg, 100-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc
FDA Drug · Class II · 2021-12-15 · Ascent Pharmaceuticals
Reason: Product Mix-up - Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg 100-count bottles, Rx Only, Manufactured for : Camber Pharmaceuticals, Inc
FDA Drug · Class II · 2020-11-25 · Ascent Pharmaceuticals
Reason: Presence of Foreign Tablet/Capsule: One bottle of Hydrocodone Bitartrate and Acetaminophen Tablets USP 10mg/325 mg contains one Losartan Potassium Tablets, USP 100 mg. - Oxycodone Hydrochloride Tablets, USP 15 mg, 100 count bottles, Rx only, Manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ, Manu…
FDA Drug · Class III · 2018-02-07 · Ascent Pharmaceuticals
Reason: Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbol